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Abstract
In doping control, to confirm the exogenous origin of exogenously administered ana-
bolic androgenic steroids (AAS), a gas chromatography combustion isotope ratio mass
spectrometry (GC-C-IRMS) analysis is performed. Recently published work suggests
that epiandrosterone sulfate (EpiAS) is a promising IRMS target compound for the
detection of AAS, capable of prolonging the detection window. However, EpiAS is
only excreted in urine in its sulfoconjugated form, while all other IRMS target com-
pounds are excreted glucuronidated, meaning that EpiAS cannot be incorporated in
the existing IRMS methods. A separate extensive sample preparation needs to be
performed on this compound with a different hydrolysis and extraction procedure
and a different liquid chromatography (LC) clean-up.
The current work presents a new, fast, and easy to implement EpiAS IRMS method.
The approach was based on the direct GC analysis of non-hydrolyzed EpiAS, making
the solid phase extraction, hydrolysis, and acetylation step redundant. Sample prepa-
ration consisted of a simple liquid–liquid extraction, followed by LC fraction collec-
tion. A population study was performed to check compliance with the criteria drafted
by the World Anti-Doping Agency (WADA). To verify the applicability of the devel-
oped approach, the method was applied to the samples of four administration studies
(i.e. dehydroepiandrosterone (DHEA), testosterone gel (T gel), androstenedione
(ADION), and intramuscular testosterone undecanoate. In contrast to previously pub-
lished data, the strength of EpiAS as the target compound and the prolongation of
the detection window in comparison with the conventional IRMS target compounds
was less pronounced.
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1 | INTRODUCTION
Testosterone (T) and its prohormones are endogenous anabolic andro-
genic steroids (AAS) that can be misused for their anabolic effects and
are therefore on the prohibited list of the World Anti-Doping Agency
(WADA).1 The detection of endogenous AAS misuse is challenging.
Determination of endogenous steroid concentrations and their ratios,
the so-called steroid profile, is conducted during the gas chromatogra-
phy mass spectrometry (GC–MS) initial testing procedure (i.e. GC–MS
screening).2,3 Quantification can point out suspicious samples, but it
cannot distinguish whether an elevation of steroid concentrations
and/or ratios is the result of the intake of a prohibited steroid, the
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influence of a confounding factor (e.g. ethanol intake, microbial degra-
dation), or intra-individual variation.4,5 To confirm whether there has
been an administration of testosterone or its precursors, a gas
chromatography-combustion-isotope ratio mass spectrometry (GC-C-
IRMS) analysis needs to be performed.6 This technique is based on
the difference between the carbon isotope ratio (CIR) of synthetic
analogs and the CIR of endogenously produced steroids. As endoge-
nous CIR values are subject to intra- and inter-individual variation and
are diet-dependent, the CIRs of the target compounds (TC) are com-
pared with the CIR of an endogenous reference compound (ERC). An
ERC (e.g. pregnanediol) is part of a different metabolic pathway from
the target compounds and is not affected by the intake of a synthetic
AAS. Exogenous administration of endogenous AAS will lead to CIRs
for the target compounds being significantly different from the CIR of
the endogenous reference compound, allowing the confirmation of an
exogenous origin.7–13
For IRMS, an extensive sample preparation is necessary to
remove all the interferences, as pure compounds need to be analyzed
for reliable CIR measurements. Such a sample preparation consists of
a solid-phase extraction (SPE), cleavage of the glucuronide
(i.e. enzymatic hydrolysis), liquid–liquid extraction (LLE), and one or
multiple liquid chromatography (HPLC) fraction collection steps. In
some IRMS methodologies, the steroids are also acetylated.
Recently, Piper et al. studied epiandrosterone sulfate (EpiAS) as a
new target compound for testosterone, 4-androstenedione (ADION),
dihydrotestosterone (DHT), and dehydroepiandrosterone (DHEA)
abuse, capable of extending the detection window.9–11 In some cases,
it prolonged the detection of a single testosterone or testosterone
prohormone administration (using the conventional target com-
pounds) from 24 h to more than 100 h. Unfortunately, EpiAS is only
excreted in urine in its sulfoconjugated form, while all other IRMS tar-
get compounds are excreted glucuronidated. This means that EpiAS
cannot be incorporated in the existing IRMS methods and a separate
extensive sample preparation needs to be performed on this com-
pound with a different hydrolysis procedure (i.e. enzymatic hydrolysis
using a sulfatase), extraction procedure, and HPLC clean-up. On
top of that, the cleavage of the sulfate group is not always
straightforward.10,14–17 As a result, doping control laboratories do not
perform IRMS analyses on EpiAS in routine practice.
Recently, our laboratory discovered that non-hydrolyzed sulfated
steroids can be analyzed directly on gas chromatography.18 Direct
injection of a non-hydrolyzed sulfated steroid results in cleavage of
the sulfate group in the GC injection port with the formation of two
isomers. This approach of directly injecting non-hydrolyzed EpiAS
enables a fast and easy to implement EpiAS IRMS method by omitting
the solid phase extraction, hydrolysis, and acetylation step (Figure 1).
2 | MATERIALS AND METHODS
2.1 | Chemicals and reagents
Potassium carbonate (K2CO3), sodium hydrogen carbonate (NaHCO3),
and sodium chloride (NaCl) were purchased from Merck (Darmstadt,
Germany). Ethyl acetate and ammonium formate (NH4OOCH) were
bought from Fisher Scientific (Leicestershire, UK) and formic acid
(HCOOH) from Fisher Scientific (Geel, Belgium).
LC–MS grade water and LC–MS grade methanol were purchased
from J. T. Baker (Deventer, the Netherlands). 5β-Pregnan-3α,20α-diol
(PD) and 17β-trenbolone (β-Tren) were bought from Sigma Aldrich
F IGURE 1 Sample preparation flowchart for
testosterone, the study of Piper et al. and the
EpiAS method [Colour figure can be viewed at
wileyonlinelibrary.com]
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(St Louis, MO, USA). 11-oxo-Etiocholanolone (11-oxo) was purchased
from Steraloids (Newport, USA), epiandrosterone sulfate was obtained
from Toronto Research Chemicals (Toronto, Canada), and the certified
standards 5α-androstane and CU-USADA 33–1 were bought from
Indiana University (Bloomington, IN, USA). Helium, carbon dioxide,
and oxygen were purchased from Air Liquide (Bornem, Belgium).
135 g of K2CO3 and 111 g of NaHCO3 were dissolved in 900 mL
of distilled water to obtain a carbonate buffer with a pH of 9.5. Ste-
roid stripped urine was prepared by pouring negative urine of an
infant onto a preconditioned XAD-2 column.
2.2 | Instruments
2.2.1 | High performance liquid chromatography –
fraction collection (HPLC-FC)
High performance liquid chromatography (HPLC) was performed on
a Thermo Scientific Surveyor (Bremen, Germany) using a Hypersil
Gold C18 column (Thermofisher Scientific, 150 × 4.6 mm; 5 μm).
100 μL of sample was injected. The mobile phases consisted of
water (A) and methanol (B), both containing 0.01% formic acid and
20 mM NH4OOCH. A gradient elution program was applied at a
constant flow rate of 1 mL/min. The gradient started at 100% A
and decreased for 1 min to 50% A. Subsequently, it decreased for
14 min to 36% after which it reached 0% in 0.1 min, where it was
kept for 2.4 min. The column was then equilibrated to starting
conditions for 3.9 min.
The HPLC was coupled to a Gilson FC 204 fraction collector (FC,
Gilson, Middleton, WI, USA). 17β-Trenbolone served as a retention
time marker as both EpiAS and β-Tren elute very close to each other.
Collection started 0.5 min before the tR of β-Tren (12.6 min) and
stopped 0.9 min after the tR of β-Tren.
2.2.2 | GC–MS
An Agilent 6890 GC, equipped with a Gerstel PTV-injector (Mulheim
an der Ruhr, Germany) was coupled to a 5975B VI MSD from Agilent
Technologies (Palo Alto, CA, USA). An Agilent J&W DB17-ms column
with a length of 30 m, internal diameter of 0.25 mm and a film thick-
ness of 0.25 μm was installed to perform separation, using helium as a
carrier gas. For the EpiAS method, a 1 μL splitless injection was used.
The injector was set at 60C. After holding at 60C for 0.15 min, the
temperature was increased at a rate of 720C/min to 280C, where it
was held for 3 min. Subsequently, the temperature was further
increased (720C/min) to 400C, where it was held for 8 min. Then
the temperature was decreased to 310C. The temperature of the col-
umn was held at 70C for 1 min before increasing the temperature to
250C with 30C/min and immediately heating to 258C at a rate of
2C/min. The final temperature of 310C, which was held for 4 min,
was reached by increasing the temperature at 60C/min. Data were
acquired using Chemstation software (Agilent, Waldbronn, Germany).
2.2.3 | GC-C-IRMS
An Agilent 7890A GC (Palo Alto, CA, USA) was coupled to a Thermo
Scientific MAT253 IRMS (Bremen, Germany), using a Thermo GC-
Isolink and a Thermo ConfloIV interface. The same GC conditions
were used as for the GC–MS analysis, but with an injection volume of
5 μL. The temperature of the combustion reactor was held at 940C.
Calibration was performed with the certified standard CU-USADA
33–1.
2.3 | Sample preparation
2.3.1 | Testosterone method
The conventional testosterone method was described elsewhere.8,13
The sample preparation consisted of a solid-phase extraction, a hydro-
lysis with β-glucuronidase (E. coli), a liquid–liquid extraction with n-
pentane and an acetylation with acetic anhydride and pyridine. Subse-
quently, HPLC-FC, GC–MS, and GC-C-IRMS were performed
(Figure 1).
2.3.2 | EpiAS method
Two 5 mL aliquots of urine were taken after which NaCl, 5 mL of
ethyl acetate, and 1 mL of carbonate buffer were added to both ali-
quots. After rolling and centrifuging the samples (2800 rpm, 5 min),
the ethyl acetate of both aliquots was transferred and combined in a
new tube where 50 μL of 17β-trenbolone was added. Then the sam-
ples were evaporated to dryness at 60C, the residue was rec-
onstituted in 110 μL of 10% methanol/water, containing 0.01%
HCOOH and 20 mM NH4OOCH, and transferred to a microfilter.
After centrifugation for 5 min, the sample was transferred to a vial
and 100 μL was injected into the HPLC-FC. The collected fraction
was dried, reconstituted, and transferred to a GC vial using 2 times
150 μL ethyl acetate. Afterwards, the solvent was evaporated to dry-
ness at 40C and reconstituted in 25 μL of 5α-androstane (5 μg/mL,
ethyl acetate). Then the samples were analyzed on GC–MS to check
for impurities. Then GC-C-IRMS analysis was performed for CIR
determination.
2.3.3 | Quality control
Quality control samples were analyzed with every batch of sam-
ples. A system blank (water) was analyzed to check for interfer-
ences in the system. A negative control urine sample
(concentration EpiAS 567 ng/mL) was prepared by aliquoting 5 mL
of the negative control urine sample used for the conventional tes-
tosterone method. A positive control urine sample was prepared
by aliquoting 1 mL of the negative control urine sample used for
the testosterone method and adding 4 mL of purified water and
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50 μL of EpiAS methanolic stock solution (100 μg/mL). A fourth
quality control sample was prepared by adding 50 μL of EpiAS
methanolic stock solution (100 μg/mL) to 5 mL steroid stripped
urine. Analyzing this extra spiked control sample aimed to exclude
that fractionation occurred during the sample preparation proce-
dure, as the CIR of this sample should have the same CIR as the
directly injected standard because there is no endogenous dilution
of EpiAS. At the beginning and end of every batch on the GC-C-
IRMS instrument, an EpiAS standard was analyzed also. This stan-
dard was prepared by pipetting 10 μL of EpiAS methanolic stock
solution (100 μg/mL) to a vial and evaporating to dryness using
oxygen-free nitrogen. The dry residue was then reconstituted in
50 μL of internal standard (IS) solution 5α-androstane in ethyl ace-
tate (5 μg/mL). The δ13C value of the internal standard 5α-
androstane was checked in every analysis to ensure that the δ13C
values generated by the IRMS were correct. The certified δ13C
value of the internal standard was −31.64‰.
2.4 | Validation
The linear range of the instrument was assessed by the analysis of ali-
quots of EpiAS standards over a range of approximately 0.3–5 V.
To evaluate the within-batch and between-batch precision of
the method, four batches were prepared and analyzed as specified
in Table 1. Each batch was prepared by spiking steroid stripped
urine (six replicates of a set concentration level per batch). Two
batches of the lowest concentration level were prepared and ana-
lyzed by two different operators. Hence, in total, 24 samples were
analyzed to evaluate the within-batch and between-batch precision
of the method.
The group of Esquivel et al.19 described concentration ranges for
EpiAS in Caucasian females, Caucasian males, and Asian males. The
10th percentile was 38.6 ng/mL, 47.8 ng/mL, and 73.8 ng/mL for the
Caucasian female, Caucasian male, and Asian male population, respec-
tively. Our LOD was set at the lowest concentration used for the pre-
cision experiments (50 ng/mL). This is a conservative LOD. It is
possible to detect lower concentrations but extraction recovery dif-
fers between samples. Taking the results of Esquivel et al.19 into
account, the LOD of the developed method was considered fit for
purpose.
Possible fractionation during the sample preparation process
was evaluated by analyzing the 24 samples used for the precision
experiment and comparing the δ13C values with the δ13C values of
enzymatically hydrolyzed EpiAS standards and the δ13C values of
chemically hydrolyzed (acidic solvolysis) EpiAS standards. The enzy-
matically hydrolyzed standards were prepared by pipetting 100 μL
of the EpiAS methanolic stock solution (100 μg/mL) and evaporat-
ing to dryness. 1 mL of acetate buffer (pH 5.2) and 50 μL of β-
glucuronidase/aryl sulfatase (Helix pomatia) were added. Samples
were incubated at 56C for 1.5 h. Afterwards, 1 mL carbonate
buffer (pH 9.5) and 5 mL methyl-tert-butyl ether were added to
perform the liquid–liquid extraction. After evaporation to dryness,
the samples were reconstituted as already described above, after
which GC–MS and GC-C-IRMS analyses were performed. The
chemically hydrolyzed standards were prepared according to the
protocols described in the works of Talbot et al.20 and Burstein
et al..21 The acidic solvolysis was carried out with ethyl
acetate/H2SO4 (10 mL/20 mg) for 1 h at 56C. Subsequently,
methanolic NaOH was added and the samples were evaporated to
dryness, after which they were dissolved in 2 mL of water and
extracted with 5 mL methyl-tert-butylether (MTBE).
To assess the specificity of the method, the 24 urine samples
from the precision experiments and an additional 61 urine samples
were extracted and analyzed with the developed method.
Bias was assessed with the linear mixing model according to the
equation δ13Cm = (δ13Ce – δ13Ca). ce/cm + δ13Ca with δ13Cm as the CIR
of the mixture, δ13Ce the endogenous CIR, and δ13Ca the CIR of the
added standard.12 Two batches of six aliquots were prepared with a
concentration ratio ce/cm range of approximately 0.3 to 1.0. The inter-
cept of the line of best fit was compared with the average CIR value
obtained by the direct injection and analysis of 56 EpiAS standards
over a period of 1 year. The difference between these two values is
defined as the bias.
Measurement uncertainty had to be lower than 1.0‰ according
to WADA's technical document on IRMS6 and is calculated by the for-
mula u (δ13C) =
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
uPrecision2 + uBias2
p
, which is described in WADA's
technical document on decision limits.22 uPrecision is the standard devi-
ation of the analysis of the negative quality control urines prepared
with every batch. uBias is calculated according to the linear mixing
model.12
2.5 | Population study
Sixty-one samples (41 male, 20 female), previously declared negative
based on IRMS results, were analyzed with the EpiAS and conven-
tional testosterone IRMS method to establish population reference
TABLE 1 Concentration levels, the average δ values and standard deviations for the evaluation of within-batch and between-batch precision
Operator Batch Concentration EpiAS (ng/mL) Concentration free EpiA (ng/mL) Average (‰) SD (‰)
A Low 1 50 39.2 −30.31 0.33
B Low 2 50 39.2 −30.69 0.38
A Medium 300 235.2 −30.79 0.27
A High 1000 783.9 −30.62 0.08
Total −30.60 0.33
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limits and to check the conformity with WADA's criteria for IRMS
analysis.6 These samples were selected randomly. To obtain a broad
variety of samples and baseline CIR values, different populations
(Western Europe, Northern Europe, and South-Africa) were included.
67 samples were analyzed of which 61 samples resulted in detectable
concentrations. Of these 61 samples, 7 samples (5 males, 2 females)
were from Northern Europe. Eight samples (7 males, 1 female) were
from South Africa. The values were tested for Gaussian distribution
using the Shapiro Wilk test (SPSS).
2.6 | Administration studies
Previous work has indicated a prolonged detection time, in compari-
son with the conventional IRMS target compounds, when using EpiAS
as a marker for AAS abuse.9–11 To verify these claims and prove that
the developed EpiAS IRMS method is fit for purpose, samples from
four administration studies from our in-house collection were
analyzed.
Dehydroepiandrosterone (DHEA), testosterone gel (T gel), andro-
stenedione (ADION), and NEBIDO were administered to four differ-
ent volunteers. These administration studies were approved by the
ethics committee of the Ghent University Hospital (B67020064707).
All volunteers signed an informed consent prior to the study. Samples
were taken at appropriate collection times depending on the duration
of activity of the administered steroid and stored frozen (−20C) until
analysis.
2.6.1 | DHEA
A healthy male volunteer (23 years old, 78 kg) was administered an
oral dose of a therapeutic preparation of 50 mg DHEA. A negative
control sample was collected prior to the administration. Post-
administration samples were collected at 4, 12, 24, 36, 48, 52, 60, 72,
76, and 84 hours.
2.6.2 | T gel
After collecting a negative control sample, T gel (Androgel, 50 mg,
CIR: −29.0‰) was administered topically to a healthy male volunteer
(25 years old, 80 kg). Post-administration samples were collected after
4, 8, 12, 24, 36, 48, 52, 60,72, 76, and 84 hours.
2.6.3 | ADION
For the ADION administration study, a healthy male volunteer
(33 years old, 92 kg, CIR: −30.7‰) was administered an oral dose
of 50 mg of ADION (Androstene Power). Post-administration
samples were collected after 2, 4, 6, 9, 12, 14, 23, 36, and
47 hours.
2.6.4 | NEBIDO
A fourth volunteer (41 years old, 72 kg, CIR: −30.37‰) was adminis-
tered a single dose of 1 g of NEBIDO intramuscularly. As this is a
long-acting testosterone preparation, post-administration samples
were collected over 87 days. A pre-administration sample and post-
administration samples after 1, 3, 4, 5, 6, 7, 9, 11, 13, 21, 27, 38,
45, 52, 59, 66, 73, 80, and 87 days were included in the study.
3 | RESULTS AND DISCUSSION
3.1 | Sample preparation
The compounds analyzed with the conventional testosterone method
are all excreted as glucuronides. The sulfated fraction is not taken
into account as they cannot be hydrolyzed by β-glucuronidase. As
EpiAS is only excreted in a sulfoconjugated form,9 it cannot be incor-
porated in the conventional testosterone method. Therefore, a differ-
ent and fast extraction procedure and HPLC clean-up were
developed. Figure 1 presents an overview of the conventional testos-
terone method, the developed EpiAS method, and the developed
method by Piper et al..10 Solid-phase extraction was a common step
between the conventional testosterone method and the method of
Piper et al.10 followed by hydrolysis, which in the work of Piper
et al.10 was preceded by a first LLE step. Previous work had demon-
strated the direct injection of non-hydrolyzed sulfated compounds
on GC–MS,18 so hydrolysis could be omitted. Another difference
between the conventional testosterone method and the method of
Piper et al.10 is the use of ethyl acetate in combination with adding
salt to extract EpiAS, instead of n-pentane or TBME, which are not
suitable due to the polarity of EpiAS. In the conventional testoster-
one method and the method of Piper et al.10 formerly
glucuronidated steroids were acetylated before performing HPLC or
SPE-FC, respectively. While Piper et al.10 used a second SPE, a sec-
ond hydrolysis, a third LLE, and an acetylation step before performing
multidimensional GC-IRMS (MDGC-C-IRMS), the samples were evap-
orated to dryness, reconstituted in mobile phase and filtered prior to
HPLC, GC–MS, and GC-C-IRMS in the EpiAS method used in this
study.
In contrast to the sample preparation steps described in the work
of Piper et al.10 the sample preparation in the developed EpiAS
method is easy to implement, less extensive, and takes less time com-
pared with the conventional testosterone method and the method of
Piper et al.10 as no SPE, hydrolysis, and acetylation are needed
because EpiAS is injected in its intact form on the GC. Subsequently,
the sulfate group is cleaved off in the injection port of the GC with
the formation of two isomers,18 as can be seen in Figure 2A. The only
disadvantage is the need for an extra aliquot of urine, besides the ali-
quot needed for the testosterone method.
Besides differences in sample preparation, the choice of mobile
phases and the column was also important in order to be able to col-
lect the appropriate fraction. The HPLC must be able to separate
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EpiAS and androsterone sulfate (AS) because they lead to the same
isomers on GC. Etiocholanolone sulfate (EtioS) and epi-
etiocholanolone sulfate (EpiEtioS) elute at retention times that differ
from EpiAS and AS. On GC, the combination of the chosen column
and temperature program ensures that both isomers coelute. By inte-
grating their peaks together on the IRMS, the right CIR is obtained. If
the peaks were integrated separately, a difference of 0.5–1‰ could
be observed. When the results of the integration of both peaks were
compared with that from a hydrolyzed standard, the CIR was
the same.
Because acetylation takes place in the conventional testosterone
method, the δ13C values of those steroids have to be converted to
their underivatized values using the equation δ13Cs = (ncd.δ13Ccd –
nd.δ13Cd_corr)/ns. In this equation, n represents the number of carbon
atoms, s the native steroid (underivatized form), d the derivative
group, and cd the derivatized compound. The δ13C values of EpiAS
were then compared with those of PD and 11-oxo by the equation
Δδ13C = δ13CERC – δ13CTC.
3.2 | Validation
A summary of the results is presented in Table 2. The slope of the
regression line is acceptable (−0.01‰/V) within the range of 0.3 V to
5 V, indicating that 0.3–5 V is a suitable interval for appropriate δ13C
determination.
The within-batch precision (repeatability) ranged from 0.08‰ to
0.38‰. The between-batch precision (reproducibility) was 0.33‰
(Table 1).
As the sulfate group of EpiAS is cleaved off during the injection, it
is important to verify that there is no fractionation when the two iso-
mers are formed. The average δ13C value in the spiked steroid
stripped urine samples was −30.60‰ with a standard deviation of
0.33‰. The average δ13C value of the enzymatically hydrolyzed stan-
dards was −30.58‰ with a standard deviation of 0.07‰. The average
δ13C value of the chemically hydrolyzed standards was −30.64‰ with
a standard deviation of 0.29‰. As the values in the urine samples are
in agreement with those of the hydrolyzed standards and it is highly
F IGURE 2 (a) Structure and IRMS analysis of EpiAS. (b) Chromatogram of a dirty sample. (c) Zoomed in chromatogram of a dirty sample
[Colour figure can be viewed at wileyonlinelibrary.com]
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unlikely that three different procedures would lead to the same
amount of fractionation, no significant fractionation occurs during the
sample preparation procedure and the injection leading to the forma-
tion of two isomers. In addition, using linear mixing models, Piper
et al.11 provided evidence that acidic solvolysis does not result in sig-
nificant fractionation.
The obtained GC chromatograms showed no major interferences
in the fraction containing the analyte of interest. In none of the sam-
ples, was coelution of EpiAS and an interference observed. In
Figure 2B, C, the chromatograms of a dirty urine sample (i.e. high uri-
nary density and high concentrations of endogenous steroids) are
presented. As this is a worst-case scenario and the peaks for EpiAS
showed no major interferences, the developed sample preparation
method was considered fit for purpose.
The δ13C values of the two batches for the linear mixing model
are presented in Figure 3. The point of intersection with the Y-axis is
−30.57‰ and the slope of the line of best fit 6.13‰. The value
obtained from the injection of 56 EpiAS standards is −30.56‰ with a
standard deviation of 0.22‰. Consequently, the bias of the method is
−0.01‰. Overall, the standard deviations for the point of inter-
section of the parameters (0.20‰) and the slope of the line of best fit
(0.10‰) are satisfactory. The average scatter of the residuals is
0.00‰ with a standard deviation of 0.23‰.
The standard deviation of EpiAS in the negative quality control
urines, prepared with every batch, was 0.45‰. Consequently, the
measurement uncertainty, calculated with ubias and uprecision, was
0.45‰, which is lower than the allowed WADA maximum of 1‰.6
3.3 | Population study
Samples were subjected to both the conventional testosterone
method and the EpiAS method.
The Shapiro–Wilk test of the Δδ13C values of PD-EpiAS and
11-oxo-EpiAS, with a confidence interval for the mean at 95%,
resulted in significance levels of 0.391 and 0.886, respectively, mean-
ing that the population values are normally distributed (P > 0.05).
Criteria have been established by WADA for the conventional
testosterone method. To meet these criteria, the mean Δδ13C + 2SD
value for ERC-TC combinations containing A, testosterone, or the
androstanediols (Adiols) as the target compounds should be lower
than, or equal to, 3‰ and the mean Δδ13C + 2SD value for ERC-TC
combinations containing Etio or epitestosterone (E) as TCs should be
lower than or equal to 4‰. The standard deviation of all Δδ13C values
should be lower than or equal to 1.2‰ for each ERC-TC
combination.6
The average of absolute EpiAS CIR values in our studied popula-
tion was −22.78‰ and the average absolute PD CIR value was
−21.88‰. The most depleted EpiAS CIR value was −25.40‰ (CIRPD:
−24.36‰) and the least depleted was −17.71‰ (CIRPD: −17.27‰).
This broad range was expected, as different populations were
included in our study.
In Figure 4, the Δδ13C values of PD-EpiAS and 11-oxo-EpiAS are
presented together with the absolute CIR values for EpiAS. The aver-
age Δδ13C + 3SD value of PD-EpiAS was 3.15‰, meaning that 3‰
would not be sufficient as a population limit. A reference population
limit of 3.30‰ will be used. The average Δδ13C + 3SD value of PD-
EpiAS was 3.24‰ and 2.94‰ for males and females, respectively.
The mean Δδ13C + 3SD value of 11-oxo-EpiAS was 3.17‰, so a
reference value of 3.20‰ will be used as reference population limit.
The average Δδ13C + 3SD value of 11-oxo-EpiAS was 3.16‰ and
2.90‰ for males and females, respectively.
3.4 | Administration studies
3.4.1 | DHEA
Figure 5 shows the Δδ13C data of the conventional ERC-TC combi-
nation with the longest detection time (PD-T) and PD-EpiAS after
the administration of DHEA and the absolute CIR values. The pop-
ulation limits of 3‰ (T) and 3.30‰ (EpiAS) are also indicated. The
TABLE 2 Linearity results within a range of 0.3–5 V
300–500 mV 500–1500 mV 1000–5000 mV
Number of measurements 5 9 4
Average (‰) −30.65 −30.60 −30.64
SD (‰) 0.09 0.06 0.02
Slope (‰/V) −0.01
F IGURE 3 Application of the linear mixing model [Colour figure
can be viewed at wileyonlinelibrary.com]
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Δδ13C values of PD-Etio, PD-βαβ (5β-androstane-3α,17β-diol), and
PD-ααβ (5α-androstane-3α,17β-diol) have values higher than 3‰
up to 36 hours post-administration. The Δδ13C value of PD-T
exceeds the threshold until 48 hours post-administration. The
Δδ13C value of PD-EpiAS is still higher than the threshold at
52 hours post-administration, meaning that the detection time is
prolonged by 4 hours compared with the conventional method,
which is a rather small advantage compared with the conventional
method.
3.5 | T gel
The Δδ13C values of PD-ααβ, which was the longest detectable
conventional TC, PD-T, and PD-EpiAS of the T gel administration
study are depicted in Figure 6, as well as the absolute CIR values.
PD-T and PD-ααβ are the only ERC-TC combinations that result in
Δδ13C values higher than 3‰. For PD-T, the values remain above
3‰ up to 12 hours post-administration. The Δδ13C values of PD-
ααβ exceed the limit of 3‰ up to 48 hours post-administration.
F IGURE 4 Boxplots of Δδ13C values for PD-EpiAS (blue) and 11-oxo-EpiAS (orange, striped) of the 61 samples from the population study.
The black, dotted boxplot represents the absolute EpiAS CIR values [Colour figure can be viewed at wileyonlinelibrary.com]
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The EpiAS Δδ13C values remain relatively stable and unaltered.
Based on these data, EpiAS seems unsuitable as a marker for
detecting a T gel misuse. However, in this study, T gel was only
applied once, which is not representative for its normal daily way
of application. In addition, due to intra-individual variation, it is
possible that for other individuals EpiAS might be a useful marker.
For example, in the study of Piper et al.10 T gel was applied for
7 consecutive days and for volunteer 1, EpiAS prolonged the
detection time by 1 day compared with ααβ-diol, which was the
longest detectable conventional target compound. For volunteer
2, the detection time was prolonged by 1 day compared with tes-
tosterone, which was the longest detectable conventional
TC. These results indicated that EpiAS is a good marker for the
detection of repeated T gel misuse.
F IGURE 5 Δδ13C results of PD-T (blue dots) and PD-EpiAS (green triangles) and absolute CIR values for testosterone (blue dots), EpiAS
(green triangles), and PD (black squares) after the administration of DHEA. The upper graph represents the Δδ13C results. The orange lines
represent the thresholds of 3‰ and 3.30‰. The lower graph represents the absolute CIR values [Colour figure can be viewed at
wileyonlinelibrary.com]
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3.5.1 | ADION
After the administration of a single dose of ADION, Δδ13C values of
PD-T exceed the threshold until 23 hours post-administration. For
PD-Etio and PD-ααβ, which were the longest detectable conventional
TCs, the Δδ13C values were higher than 3‰ until 36 hours post-
administration. PD-βαβ and PD-EpiAS remained above 3‰ until the
end of the study (Figure 7). From 12 hours up to the end of the study,
the Δδ13C value of PD-EpiAS remains relatively stable (i.e., around
4‰), whereas the Δδ13C value of PD-βαβ decreases from 7.2‰ to
3.7‰. It is likely that EpiAS remains above its population reference
limit for a longer period of time than PD-βαβ and, as such, prolongs
the detection time. Unfortunately, this could not be verified as
47 hours was the last collection time. A longer detection time was
F IGURE 6 Δδ13C data of PD-ααβ (red open circles), PD-T (blue dots), and PD-EpiAS (green triangles) and absolute CIR values for ααβ (red
open circles), testosterone (blue dots), EpiaS (green triangles), and PD (black squares) after the administration of T gel. The upper graph represents
the Δδ13C results. The orange lines represent the thresholds of 3‰ and 3.30‰. The lower graph represents the absolute CIR values [Colour
figure can be viewed at wileyonlinelibrary.com]
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reported by Piper et al.10 The CIR of the conventional metabolites ret-
urned to baseline values within 24 hours post-administration while
the CIR of EpiAS remained depleted up to 130 hours.
3.5.2 | NEBIDO
For the NEBIDO excretion samples, the Δδ13C values of PD-ααβ and
PD-T exceeded the reference threshold until the end of the study
(i.e. 87 days). PD-Etio and PD-βαβ exceeded the reference threshold
until 52 days. PD-A returned to unsuspicious values after 21 days. As
visualized in Figure 8, EpiAS was less depleted than ααβ and T and
remained above its reference threshold from day 5 until day 73. A final
conclusion cannot be drawn based on these data, but it seems that
the conventional TCs and EpiAS have the same trend of returning to
baseline values and that EpiAS will probably not extend the detection
time. However, additional data are needed to confirm this conclusion.
F IGURE 7 Δδ13C results of PD-βαβ (grey dots) and PD-EpiAS (green triangles) and absolute CIR values for βαβ (grey dots), EpiAS (green
triangles), and PD (black squares) after the administration of ADION. The upper graph represents the Δδ13C results. The orange lines represent
the thresholds of 3‰ and 3.30‰. The lower graph represents the absolute CIR values [Colour figure can be viewed at wileyonlinelibrary.com]
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4 | CONCLUSION
A fast and easily implementable GC-C-IRMS method for EpiAS was
developed and validated. The approach is based on the direct GC
analysis of non-hydrolyzed EpiAS, making the solid phase extraction,
hydrolysis, and acetylation step redundant. Sample preparation con-
sisted of a simple liquid–liquid extraction, followed by LC fraction col-
lection, which was an appropriate sample preparation as there were
no interferences observed.
Δδ13C population reference limits of 3.30‰ and 3.20‰ were
established for PD-EpiAS and 11-oxo-EpiAS, respectively. The con-
ducted administration studies confirm, to a certain extent, previous
studies and show the usefulness of EpiAS as an extra TC to prolong
the IRMS detection times. After administration, EpiAS δ13C values
depleted more slowly in comparison with the conventional TCs, but
also remained depleted for a longer time period, leading to longer
detection times. However, in the current study, this was less pro-
nounced than in previous studies. Slightly longer detection times were
assessed for DHEA and most likely for ADION as well. EpiAS did not
result in longer detection times for a single administration of T gel.
For NEBIDO, it is most likely that EpiAS will not extend the detection
time compared with the conventional TCs but additional data are
needed to confirm this statement. As such, the collected data do sug-
gest that more administration studies are required to map comprehen-
sively the advantages of EpiAS as TC in comparison with the
conventional TCs.
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